IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Broadwood Capital Inc

Q4 2023 Holdings

Filed 2024-02-14 | 7 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Monster Beverage Corp New(MNST)COM61174X109$489.0M8,488,01741.7%
Staar Surgical Co(STAA)COM PAR $0.01852312305$328.9M10,537,83528.0%
Axon Enterprise Inc(AXON)COM05464C101$196.3M760,06216.7%
Ishares TR(IWM)RUSSELL 2000 ETF464287655$113.6M566,0009.7%
Lineage Cell Therapeutics in(LCTX)COM53566P109$38.1M34,935,4853.2%
Oncocyte Corp(IMDX)COM NEW68235C206$6.3M2,509,0660.5%
Agex Therapeutics Inc(AGEGBP)COM00848H108$1.2M2,997,1560.1%